XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Changes in Stockholders’ Equity - USD ($)
Total
Common Stock
Treasury Stock
Additional Paid in Capital
Accumulated Deficit
Series 1 Convertible Preferred Stock
Preferred Stock
Series 2 Convertible Preferred Stock
Preferred Stock
Preferred stock, beginning balance (in shares) at Dec. 31, 2022           170,332 21,952
Beginning balance at Dec. 31, 2022 $ 31,034,673 $ 2,176 $ 39,819,420 $ (31,590,583) $ 851,660 $ 21,952,000
Common stock, beginning balance (in shares) at Dec. 31, 2022   21,750,804          
Beginning balance, treasury stock (in shares) at Dec. 31, 2022            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Provision for compensation expense related to stock-based compensation 420,748     420,748      
Exercise of stock options into common stock (in shares)   1,500          
Exercise of stock options into common stock 1,185     1,185      
Net income/ (loss) (230,215)       (230,215)    
Preferred stock, ending balance (in shares) at Mar. 31, 2023           170,332 21,952
Ending balance at Mar. 31, 2023 31,226,391 $ 2,176 $ 0 40,241,353 (31,820,798) $ 851,660 $ 21,952,000
Common stock, ending balance (in shares) at Mar. 31, 2023   21,752,304          
Ending balance, treasury stock (in shares) at Mar. 31, 2023     0        
Preferred stock, beginning balance (in shares) at Dec. 31, 2022           170,332 21,952
Beginning balance at Dec. 31, 2022 31,034,673 $ 2,176 39,819,420 (31,590,583) $ 851,660 $ 21,952,000
Common stock, beginning balance (in shares) at Dec. 31, 2022   21,750,804          
Beginning balance, treasury stock (in shares) at Dec. 31, 2022            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income/ (loss) (4,587,769)            
Preferred stock, ending balance (in shares) at Sep. 30, 2023           170,332 21,952
Ending balance at Sep. 30, 2023 28,601,812 $ 2,176 $ (100,225) 42,074,553 (36,178,352) $ 851,660 $ 21,952,000
Common stock, ending balance (in shares) at Sep. 30, 2023   21,752,304          
Ending balance, treasury stock (in shares) at Sep. 30, 2023     100,775        
Preferred stock, beginning balance (in shares) at Mar. 31, 2023           170,332 21,952
Beginning balance at Mar. 31, 2023 31,226,391 $ 2,176 $ 0 40,241,353 (31,820,798) $ 851,660 $ 21,952,000
Common stock, beginning balance (in shares) at Mar. 31, 2023   21,752,304          
Beginning balance, treasury stock (in shares) at Mar. 31, 2023     0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Provision for compensation expense related to stock-based compensation 443,800     443,800      
Extension of warrants 917,581     917,581      
Net income/ (loss) (5,297,655)       (5,297,655)    
Preferred stock, ending balance (in shares) at Jun. 30, 2023           170,332 21,952
Ending balance at Jun. 30, 2023 27,290,117 $ 2,176 $ 0 41,602,734 (37,118,453) $ 851,660 $ 21,952,000
Common stock, ending balance (in shares) at Jun. 30, 2023   21,752,304          
Ending balance, treasury stock (in shares) at Jun. 30, 2023     0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Provision for compensation expense related to stock-based compensation 471,819     471,819      
Purchases of treasury stock (in shares)     100,775        
Purchases of treasury stock (100,225)   $ (100,225)        
Net income/ (loss) 940,101       940,101    
Preferred stock, ending balance (in shares) at Sep. 30, 2023           170,332 21,952
Ending balance at Sep. 30, 2023 28,601,812 $ 2,176 $ (100,225) 42,074,553 (36,178,352) $ 851,660 $ 21,952,000
Common stock, ending balance (in shares) at Sep. 30, 2023   21,752,304          
Ending balance, treasury stock (in shares) at Sep. 30, 2023     100,775        
Preferred stock, beginning balance (in shares) at Dec. 31, 2023           170,332 21,952
Beginning balance at Dec. 31, 2023 $ 29,230,773 $ 2,176 $ (166,757) 42,415,894 (35,824,200) $ 851,660 $ 21,952,000
Common stock, beginning balance (in shares) at Dec. 31, 2023   21,752,304          
Beginning balance, treasury stock (in shares) at Dec. 31, 2023 164,029   164,029        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Provision for compensation expense related to stock-based compensation $ 217,125     217,125      
Purchases of treasury stock (in shares)     5,418        
Purchases of treasury stock (6,098)   $ (6,098)        
Net income/ (loss) (214,179)       (214,179)    
Preferred stock, ending balance (in shares) at Mar. 31, 2024           170,332 21,952
Ending balance at Mar. 31, 2024 29,227,621 $ 2,176 $ (172,855) 42,633,019 (36,038,379) $ 851,660 $ 21,952,000
Common stock, ending balance (in shares) at Mar. 31, 2024   21,752,304          
Ending balance, treasury stock (in shares) at Mar. 31, 2024     169,447        
Preferred stock, beginning balance (in shares) at Dec. 31, 2023           170,332 21,952
Beginning balance at Dec. 31, 2023 $ 29,230,773 $ 2,176 $ (166,757) 42,415,894 (35,824,200) $ 851,660 $ 21,952,000
Common stock, beginning balance (in shares) at Dec. 31, 2023   21,752,304          
Beginning balance, treasury stock (in shares) at Dec. 31, 2023 164,029   164,029        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Purchases of treasury stock (in shares) 362,793            
Purchases of treasury stock $ (396,780)            
Net income/ (loss) 549,147            
Preferred stock, ending balance (in shares) at Sep. 30, 2024           170,332 21,952
Ending balance at Sep. 30, 2024 $ 29,808,572 $ 2,200 $ (563,537) 42,841,302 (35,275,053) $ 851,660 $ 21,952,000
Common stock, ending balance (in shares) at Sep. 30, 2024   21,988,711          
Ending balance, treasury stock (in shares) at Sep. 30, 2024 526,822   526,822        
Preferred stock, beginning balance (in shares) at Mar. 31, 2024           170,332 21,952
Beginning balance at Mar. 31, 2024 $ 29,227,621 $ 2,176 $ (172,855) 42,633,019 (36,038,379) $ 851,660 $ 21,952,000
Common stock, beginning balance (in shares) at Mar. 31, 2024   21,752,304          
Beginning balance, treasury stock (in shares) at Mar. 31, 2024     169,447        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Provision for compensation expense related to stock-based compensation 154,873     154,873      
Purchases of treasury stock (in shares)     176,811        
Purchases of treasury stock (194,708)   $ (194,708)        
Net income/ (loss) (1,603,058)       (1,603,058)    
Vesting of performance share units, net of share withheld for employee taxes (in shares)   236,407          
Vesting of performance share units, net of share withheld for employee taxes (103,488) $ 24   (103,512)      
Preferred stock, ending balance (in shares) at Jun. 30, 2024           170,332 21,952
Ending balance at Jun. 30, 2024 27,481,240 $ 2,200 $ (367,563) 42,684,380 (37,641,437) $ 851,660 $ 21,952,000
Common stock, ending balance (in shares) at Jun. 30, 2024   21,988,711          
Ending balance, treasury stock (in shares) at Jun. 30, 2024     346,258        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Provision for compensation expense related to stock-based compensation 156,922     156,922      
Purchases of treasury stock (in shares)     180,564        
Purchases of treasury stock (195,974)   $ (195,974)        
Net income/ (loss) 2,366,384       2,366,384    
Preferred stock, ending balance (in shares) at Sep. 30, 2024           170,332 21,952
Ending balance at Sep. 30, 2024 $ 29,808,572 $ 2,200 $ (563,537) $ 42,841,302 $ (35,275,053) $ 851,660 $ 21,952,000
Common stock, ending balance (in shares) at Sep. 30, 2024   21,988,711          
Ending balance, treasury stock (in shares) at Sep. 30, 2024 526,822   526,822